| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Volpone John serves as a President at XFOR. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.2M at current prices.
The biggest single holding is XFOR (~$1.2M) as President. The recent filings there lean toward selling, a net 24,576 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | XFOR X4 Pharmaceuticals, Inc. | President | Sell | 24,576 | $4.44 | $109,228.03 | -8.5% | - | - |